Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies

α-Synuclein is a protein with a molecular weight of 14.5 kDa and consists of 140 amino acids encoded by the <i>SNCA</i> gene. Missense mutations and gene duplications in the <i>SNCA</i> gene cause hereditary Parkinson’s disease. Highly phosphorylated and abnormally aggregated...

Full description

Bibliographic Details
Main Authors: Ichiro Kawahata, David I. Finkelstein, Kohji Fukunaga
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/11/6216
_version_ 1797493016328404992
author Ichiro Kawahata
David I. Finkelstein
Kohji Fukunaga
author_facet Ichiro Kawahata
David I. Finkelstein
Kohji Fukunaga
author_sort Ichiro Kawahata
collection DOAJ
description α-Synuclein is a protein with a molecular weight of 14.5 kDa and consists of 140 amino acids encoded by the <i>SNCA</i> gene. Missense mutations and gene duplications in the <i>SNCA</i> gene cause hereditary Parkinson’s disease. Highly phosphorylated and abnormally aggregated α-synuclein is a major component of Lewy bodies found in neuronal cells of patients with sporadic Parkinson’s disease, dementia with Lewy bodies, and glial cytoplasmic inclusion bodies in oligodendrocytes with multiple system atrophy. Aggregated α-synuclein is cytotoxic and plays a central role in the pathogenesis of the above-mentioned synucleinopathies. In a healthy brain, most α-synuclein is unphosphorylated; however, more than 90% of abnormally aggregated α-synuclein in Lewy bodies of patients with Parkinson’s disease is phosphorylated at Ser129, which is presumed to be of pathological significance. Several kinases catalyze Ser129 phosphorylation, but the role of phosphorylation enzymes in disease pathogenesis and their relationship to cellular toxicity from phosphorylation are not fully understood in α-synucleinopathy. Consequently, this review focuses on the pathogenic impact of α-synuclein phosphorylation and its kinases during the neurodegeneration process in α-synucleinopathy.
first_indexed 2024-03-10T01:13:56Z
format Article
id doaj.art-315eb0a65332473e8fe99dc86c1e6058
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T01:13:56Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-315eb0a65332473e8fe99dc86c1e60582023-11-23T14:11:37ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-06-012311621610.3390/ijms23116216Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-SynucleinopathiesIchiro Kawahata0David I. Finkelstein1Kohji Fukunaga2Department of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, JapanFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3010, AustraliaDepartment of CNS Drug Innovation, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japanα-Synuclein is a protein with a molecular weight of 14.5 kDa and consists of 140 amino acids encoded by the <i>SNCA</i> gene. Missense mutations and gene duplications in the <i>SNCA</i> gene cause hereditary Parkinson’s disease. Highly phosphorylated and abnormally aggregated α-synuclein is a major component of Lewy bodies found in neuronal cells of patients with sporadic Parkinson’s disease, dementia with Lewy bodies, and glial cytoplasmic inclusion bodies in oligodendrocytes with multiple system atrophy. Aggregated α-synuclein is cytotoxic and plays a central role in the pathogenesis of the above-mentioned synucleinopathies. In a healthy brain, most α-synuclein is unphosphorylated; however, more than 90% of abnormally aggregated α-synuclein in Lewy bodies of patients with Parkinson’s disease is phosphorylated at Ser129, which is presumed to be of pathological significance. Several kinases catalyze Ser129 phosphorylation, but the role of phosphorylation enzymes in disease pathogenesis and their relationship to cellular toxicity from phosphorylation are not fully understood in α-synucleinopathy. Consequently, this review focuses on the pathogenic impact of α-synuclein phosphorylation and its kinases during the neurodegeneration process in α-synucleinopathy.https://www.mdpi.com/1422-0067/23/11/6216α-synucleinphosphorylationParkinson’s diseasedementia with Lewy bodiesmultiple system atrophyα-synucleinopathy
spellingShingle Ichiro Kawahata
David I. Finkelstein
Kohji Fukunaga
Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
International Journal of Molecular Sciences
α-synuclein
phosphorylation
Parkinson’s disease
dementia with Lewy bodies
multiple system atrophy
α-synucleinopathy
title Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
title_full Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
title_fullStr Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
title_full_unstemmed Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
title_short Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
title_sort pathogenic impact of α synuclein phosphorylation and its kinases in α synucleinopathies
topic α-synuclein
phosphorylation
Parkinson’s disease
dementia with Lewy bodies
multiple system atrophy
α-synucleinopathy
url https://www.mdpi.com/1422-0067/23/11/6216
work_keys_str_mv AT ichirokawahata pathogenicimpactofasynucleinphosphorylationanditskinasesinasynucleinopathies
AT davidifinkelstein pathogenicimpactofasynucleinphosphorylationanditskinasesinasynucleinopathies
AT kohjifukunaga pathogenicimpactofasynucleinphosphorylationanditskinasesinasynucleinopathies